Topics

Latest "TerraVerdae BioWorks" News Stories

22:39 EDT 22nd July 2019 | BioPortfolio

Here are the most relevant search results for "TerraVerdae BioWorks" found in our extensive news archives from over 250 global news sources.

More Information about TerraVerdae BioWorks on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about TerraVerdae BioWorks for you to read. Along with our medical data and news we also list TerraVerdae BioWorks Clinical Trials, which are updated daily. BioPortfolio also has a large database of TerraVerdae BioWorks Companies for you to search.

Showing "TerraVerdae BioWorks" News Articles 1–25 of 28

Sunday 23rd June 2019

Ginkgo Bioworks’ new Chairman Marijn Dekkers on technology, marketing, and the synthetic biology consumer

Last month, Ginkgo Bioworks announced the appointment of Marijn Dekkers as Chairman of its Board of Directors and strategic advisor. Dekkers has enjoyed a long and successful career in the technology and life sciences industries, beginning as a researcher at General Electric in 1985 and serving as CEO for companies ranging from Thermo Fisher Scientific […] The post Ginkgo Bioworks’ new Cha...


Thursday 13th June 2019

. @synlogic_tx will use @Ginkgo Bioworks’ cell programming platform to expand and further develop a pipeline of novel “living” medicines based on engineered probiotics: http://ow.ly/uWqU50uD9Z4 

. @synlogic_tx will use @Ginkgo Bioworks’ cell programming platform to expand and further develop a pipeline of novel “living” medicines based on engineered probiotics: http://ow.ly/uWqU50uD9Z4 

Synlogic and Ginkgo Bioworks to develop biotic drugs

Synlogic has entered a platform collaboration with biotech company Ginkgo Bioworks to support its synthetic bionic medicines pipeline. The alliance...Read More... The post Synlogic and Ginkgo Bioworks to develop biotic drugs appeared first on Pharmaceutical Technology.


Synlogic and Ginkgo Bioworks Enter Platform Collaboration for Accelerated Development of Novel Synthetic Biotic Medicines

CAMBRIDGE, Mass. & BOSTON–(BUSINESS WIRE)–Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to beneficial microbes to develop novel, living medicines and Ginkgo Bioworks, the organism company, today announced a platform collaboration to accelerate expansion and development of Synlogic’s pipeline of Synthetic Biotic medicines using Ginkgo’s ce...

Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments

Synlogic will use Ginkgo Bioworks’ cell programming platform to expand and further develop a pipeline of novel “living” medicines based on engineered probiotics, building upon a 1½-year-old collaboration launched by the companies. The post Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments appeared first on GEN - Genetic Engineering ...

Wednesday 12th June 2019

Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D

[Updated 10:42 a.m., see below.] Synlogic, a developer of so-called “living medicines” comprised of engineered bacteria, is teaming up with synthetic biology company Ginkgo Bioworks in an effort to advance drug candidates to human testing more quickly. Under an agreement announced Wednesday, Cambridge, MA-based Synlogic (NASDAQ: SYBX) will use Ginkgo’s technology to design and test […]

Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines

– Fuels development of Synlogic’s growing pipeline of novel living medicines with technology access and $80.0 million equity investment at a premium – – Applies Ginkgo’s high-throughput synthetic biology platform services to human therapeutics – – Synlogic to host a conference call at 8:00 am ET today – Synlogic...

Sunday 9th June 2019

Global Crop Protection Products Market Research Report 20122024 [Report Updated: 25052019] Prices from USD $2080

SummaryThe global Crop Protection Products market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report descri...

Thursday 6th June 2019

California Life Sciences Institute (CLSI) to Launch Program Showcasing Emerging Life Science Companies from Around the World

First-ever showcase to feature 12 startups on June 11 at UCSF’s Genentech Hall The California Life Sciences Institute (CLSI) invites media to attend its first-ever International Showcase for Life Science Startups and Emerging Companies on Tuesday, June 11, 2019, at UCSF’s Genentech Hall in Mission Bay, San Francisco. CLSI’s mission is to m...

Global Seed Treatment Products Market Research Report 20122024 [Report Updated: 23052019] Prices from USD $2180

SummaryThe global Seed Treatment Products market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describ...

Friday 31st May 2019

International Cannabis, Biotii and Y Combinator Backed Biotech Innovator to Build Bioworks Foundry

VANCOUVER, British Columbia, May 30, 2019 – ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (“ICC” or “International Cannabis” or the “Company”) is pleased to announce that the Company, alongside Biotii Technologies Corp. (“Biotii”) has entered into a design and automation agreement (the “Agreement”) with Y Combinator backed Opentrons Labworks Inc. (“O...

Thursday 30th May 2019

BIO Announces 2019 Rosalind Franklin Award Winner: Reshma Shetty, Gingko Bioworks

In the 1950s, while a research associate at King’s College, Rosalind Franklin made the single ...

IRW-News: ICC International Cannabis Corp: International Cannabis, Biotii und Y Combinator unterstützen Biotech-Innovator bei Errichtung von Bioworks Foundry

IRW-PRESS: ICC International Cannabis Corp: International Cannabis, Biotii und Y Combinator unterstützen Biotech-Innovator bei Errichtung von Bioworks Foundry Vancouver (British Columbia), 30. Mai...

Wednesday 15th May 2019

Ginkgo Bioworks Buys Warp Drive Bio’s Genome Mining Platform

Ginkgo Bioworks bought Warp Drive Bio’s genome mining platform, which includes its genome mining team, technology and database.

Ginkgo Eyes Antibiotics With Deal for Warp Drive’s Gene “Mining” Tech

Microbes designed by Ginkgo Bioworks are used in consumer products such as fragrances and beverages, and they’re undergoing research for applications in agriculture and medicine. The synthetic biology company has been pushing to expand its technology to more uses, and its latest deal moves the firm further into pharmaceutical research. Boston-based Ginkgo said Wednesday that […]

#news #biotech Ginkgo buys genome mining platform from Warp Drive Bio, takes over Roche pact

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ginkgo buys genome mining platform from Warp Drive Bio, takes over Roche pact .Ginkgo Bioworks is buying Warp Drive Bio’s genome mining team, tech and database, eyeing the … Continue reading →

Ginkgo Bioworks Acquires Warp Drive Bio’s Genome Mining Platform for Discovery and Development of Novel Classes of Antibiotics

Acquisition expands Ginkgo’s biological codebase for organism engineering for the production of natural product pharmaceuticals Genome mining team, technology and biological database complement Ginkgo’s automated organism engineering platform to advance efforts against drug-resistant bacterial infections BOSTON, May 15, 2019 /PRNewswire/ — Ginkgo Bioworks, the organism company, ...

Microbe-Hacker Ginkgo Bioworks Pushes Further Into Medicine With Acquisition Of Genome Mining Platform And Antibiotics Discovery Deal With Roche

Gene-hacking unicorn Ginkgo Bioworks pushed further into medicine with the acquisition of Warp Drive Bio's genome mining platform and its antibiotics discovery deal with Roche. "This is a big part of the future of Ginkgo," CEO Jason Kelly told Forbes.

Tuesday 16th April 2019

Management tracks: Ginkgo Bioworks, KSQ, Milestone, Cerebral

Monday 11th March 2019

Australian Industry Welcomes Possible Oral Contraceptive Switch

In a move welcomed by industry, the Australian Labor Party has pledged it would task if elected the country’s federal...    

Sunday 10th March 2019

Wellness Industry News: MacKay Leaving CRN; Another Life-Line Recall, Ginkgo Bioworks' Second Startup, More

Duffy MacKay is leaving CRN and Andrew Shao will return for an interim period; McDaniel Life-Line recalls all lots of...    

Friday 8th March 2019

GNC, Vitamin Shoppe Not On Same Page In Solving Similar Growth Challenges

Common thread between the manufacturers and retail chain operators offering their own and other brands extends to relatively recent executive...   &

Thursday 28th February 2019

Billionaire investors led by Bill Gates back biotech start-up Ginkgo Bioworks to expand plant-based meat industry

Wednesday 27th February 2019

Motif Ingredients raises $90M to develop plant-based meats

Ginkgo Bioworks has launched a startup called Motif Ingredients that aims to identify and develop protein ingredients for use -More- 

Tuesday 26th February 2019

Ginkgo bets on future food tech with spin-out Motif Ingredients

It’s the largest Series A in food tech history: Ginkgo Bioworks today announced the $90 million launch of Motif Ingredients, a spin-out company that aims to provide next-generation alternative proteins and other ingredients to food companies worldwide. The new company will leverage Ginkgo’s biological engineering platform to create novel food solutions that give consumers greater […] The...


Quick Search

News Quicklinks